Community News

IRVINE, Calif.--(BUSINESS WIRE)--Endologix, Inc. (Nasdaq: ELGX) (“Endologix” or the “Company”), a developer and marketer of innovative treatments for aortic disorders, announced today that it has entered into an exchange agreement with three holders of the Company’s 3.25% Senior Convertible Notes due 2020 (the “Existing Notes”), pursuant to which these investors exchanged an aggregate of approximately $11.0 million of the Existing Notes plus accrued […]

CULVER CITY, Calif.--(BUSINESS WIRE)--NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, today announced that it will report financial results for its 2019 fourth quarter on Friday, February 28, 2020, after market close. NantHealth management will host a conference call that same day at 1:30 p.m. PT (4:30 p.m. ET) to review the company’s performance. The conference call will be available to interested parties by dialing 844-309-3709 from […]

LOS ANGELES--(BUSINESS WIRE)--On Feb. 20, 2020, Puma Biotechnology released its financial results for the fourth quarter and full year ended Dec. 31, 2019.

LOS ANGELES--(BUSINESS WIRE)--Investigators at Children's Hospital Los Angeles measure brain temperature in infants, demonstrating that cooling therapy effectively targets brain

IRVINE, Calif.--(BUSINESS WIRE)--Masimo (Nasdaq: MASI) today announced its financial results for the fourth quarter and full-year ended December 28, 2019. Fourth Quarter 2019 Results: Total revenue, including royalty and other revenue, was $247.5 million. Product revenues increased 11.8% to $247.4 million, or 12.0% on a constant currency basis. Shipments of noninvasive technology boards and monitors increased 1.8% to 61,400 in the fourth quarter of 2019, compared to 60,300 in the fourth quarter

IRVINE, Calif.--(BUSINESS WIRE)--Endologix, Inc. (the “Company”) (NASDAQ: ELGX), a developer and marketer of innovative treatments for aortic disorders, today announced financial results for the fourth quarter and fiscal year ended December 31, 2019. Global revenue in the fourth quarter of 2019 was $35.8 million, a 3.0% increase from $34.7 million in the fourth quarter of 2018. For the year ended December 31, 2019, global revenue was $143.4 million, an 8.4% decrease from $156.5 […]

TUSTIN, Calif.--(BUSINESS WIRE)--Canon Medical Systems USA, Inc. has received 510(k) clearance for the Aquilion ONE / PRISM Edition, enabling Deep Learning Spectral capabilities that allow for more routine spectral imaging. Designed for deep intelligence, the advanced system integrates artificial intelligence (AI) technology to maximize conventional and spectral CT capabilities with automated workflows, while providing deep clinical insights to assist physicians in making more informed decision

IRVINE, Calif.--(BUSINESS WIRE)--Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company that has developed and is commercializing novel implantable rechargeable Sacral Neuromodulation (“SNM”) devices for the treatment of urinary and bowel dysfunction, today announced that it will release financial results for the 2019 fourth quarter and full year, and provide an update on U.S. launch activities after the market closes on Wednesday, March 4, 2020. In […]

HUNTINGTON BEACH, Calif.--(BUSINESS WIRE)-- #asrm--Cicero Diagnostics announces NIH grant award to further studies of biomarkers to help resolve unexplained infertility and failed implantation.

VALENCIA, Calif. & MELBOURNE, Australia--(BUSINESS WIRE)--AVITA Medical Limited (ASX: AVH, NASDAQ: RCEL), a regenerative medicine company with a technology platform positioned to address unmet medical needs in therapeutic skin restoration, announced that it filed today with the Australian Securities Exchange (ASX) its Appendix 4D – Half-Year Report for the six month period ended 31 December 2019. Revenues of RECELL® System for First Six Month Period Ended 31 December 2019   […]

CLAREMONT, Calif.--(BUSINESS WIRE)--Synedgen to Present Data on Therapeutic for Ocular Mustard Gas Injury at NIH-Organized Medical Countermeasures Meeting

MONROVIA, Calif.--(BUSINESS WIRE)--Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of cancer and autoimmune diseases, today announced that it will release fourth quarter and full year 2019 financial results after the market closes on Monday, February 24, 2020. Xencor management will host a webcast and conference call the same day at 4:30 p.m. ET (1:30 p.m. PT) to discuss the financial results and provide a cor

IRVINE, Calif.--(BUSINESS WIRE)--Endologix, Inc. (Nasdaq: ELGX), a developer and marketer of innovative treatments for aortic disorders, today announced that Vaseem Mahboob, Chief Financial Officer, will present at the 9th Annual SVB Leerink Global Healthcare Conference at 3:00 p.m. ET on Wednesday, February 26, 2020 in New York, NY. A live webcast of the presentation will be accessible through the “Investors” section of the Company’s website at www.endologix.com and will be […]

TUSTIN, Calif.--(BUSINESS WIRE)--Bionet America, Inc. announces the launch of the long awaited BMVet PRO Series of Veterinary specific multiparameter monitors. The BMVet PRO series have been carefully engineered with 100% Veterinary specific modules and algorithms. Bionet America plans to introduce the new monitors to the public at this year’s 2020 WVC conference in Las Vegas, NV from 2/16-2/19. WVC attendees can visit booth #4142 for a demonstration of the new monitors. The new monitor […]

LAGUNA BEACH, Calif.--(BUSINESS WIRE)--Cardiovascular diseases are the No. 1 cause of death worldwide each year. In the U.S. alone, over 1,000 people die of sudden cardiac arrest (SCA) each day. CardioThrive was founded to increase the SCA survival rate from the current average of about 5 percent to over 50 percent. At the Emerging MedTech Summit, CEO Shelley Savage will discuss how CardioThrive has developed a pocket-size automated external defibrillator (AED). By making AEDs as portable as a

IRVINE, Calif. & BASEL, Switzerland--(BUSINESS WIRE)--Urovant Sciences Reports 2019 Third Fiscal Quarter Financial Results

SEAL BEACH, Calif.--(BUSINESS WIRE)-- #gu20--New study of 6,000+ Medicare patients with advanced prostate cancer shows adding PROVENGE (sipuleucel-T) to treatment reduced risk of death by 45%.

LAGUNA NIGUEL, Calif.--(BUSINESS WIRE)-- #innovation--Christopher J. Velis, Chairman of Miraki Innovation and Co-Founder of Auris Health (acquired by J&J for $5.7B) will deliver the keynote address at the Life Science Intelligence (LSI) Emerging Medtech Summit February 18-20th, 2020 at The Ritz-Carlton in Laguna Niguel, CA. In his keynote, “The Next Quantum Leaps in Medtech,” Velis will share his insights on a repeatable process for quantum leaps of innovation. He’ll […]

NEWPORT BEACH, Calif.--(BUSINESS WIRE)--ImmunogenX is pleased to announce that patient enrollment has begun for a Phase 2b clinical trial (NCT04243551, named “Solutions for Celiac”™). This trial is funded by the National Institutes of Health’s (NIH) National Institute of Allergy and Infectious Diseases (NIAID) as a grant to ImmunogenX. The multi-center trial includes Columbia University in New York, NY; Mayo Clinic in Rochester, MN; and private practice sites located in […]

LOS ANGELES--(BUSINESS WIRE)--In the first human study, CHLA investigators find that the carbohydrate 2'FL in breast milk enhances cognitive development